Prevalence, awareness, and control of arterial hypertension in Denmark

Journal of the American Society of Hypertension

Volumn 3, Issue 1, 2009, Pages

  Kronborg, Christel N ^a   Hallas, Jesper ^a   Jacobsen, Ib A ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

antihypertensive therapy; blood pressure; detection; Epidemiology

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE;

EID: 58549083529     PISSN: 19331711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jash.2008.08.001     Document Type: Article

References (23)

1. Ezzati M., Lopez A.D., Rodgers A., van der Horn S., and Murray C.J.L. Selected major risk factors and global and regional burden of disease. Lancet 360 (2002) 1347-1360
2. WHO. World health report 2002; reducing risk, promoting healthy life (2002), World Health Organization, Geneva, Switzerland
3. Blood Pressure Lowering Treatment Trialists' Collaboration. Effect of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trails. Lancet 362 (2003) 1527-1535
4. Mancia G., and Grassi G. Systolic and diastolic blood pressure control in antihypertensive drug trials. J Hypertens 20 (2002) 1461-1464
5. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P., and He Jiang. Worldwide prevalence of hypertension: a systematic review. J Hypertens 22 (2004) 11-19
6. Kearney P.M., Whelton M., Reynolds K., Muntner P., Whelton P., and He J. Global burden of hypertension: analysis of worldwide data. Lancet 365 (2005) 217-223
7. Burt V.L., Cutler A.J., Higgins M., Horan M.J., Labarthe D., Whelton P., et al. Trends in the prevalence, awareness, treatment and control of hypertension in the US adult population. Hypertension 26 (1995) 60-69
8. Sehested T., Ibsen H., and Jøgensen T. Awareness, treatment and control of hypertension in Denmark. The Inter99 study. Blood Press 16 (2007) 312-319
9. Rogoza A.N., Pavlova T.S., and Sergeeva M.V. Validation of A&D UA-676 device for self-measurement of blood pressure. Blood Press Monitor 5 (2000) 227-231
10. 2003 European Society of Hypertension-European Society of Cardiology guide lines for the management of arterial hypertension. J Hypertens 21 (2003) 1011-1053
11. Klungel O.H., de Boer A., Paes A.H.P., Nagelkerke N.J.D., Seidell J.C., and Bakker A. Estimating the prevalence of hypertension corrected for the effect of within-person variability in blood pressure. J Clin Epidemiol 53 (2000) 1158-1163
12. Longo D., Dorigatti P., and Palatini F. Masked hypertension in adults. Blood Press Monitor 10 (2005) 307-310
13. Pickering T.G., Davidson K., Gerin W., and Schwartz J.E. Masked hypertension. Hypertension 40 (2002) 795-796
14. Mancia G. Effective ambulatory blood pressure control in medical practice. Hypertension 49 (2007) 17-18
15. Kaplan G.A., and Keil J.E. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 88 (1993) 1973-1998
16. Erdine S. Eur Soc Hypertens Scient Newsl 2007. www.eshonline.org/education/newsletter/2007_03.pdf
17. Orduñez-Garcia P., Bernal Munoz J.L., Pedraza D., Espinosa-Brito A., Silva L.C., and Cooper R.S. Success in control of hypertension in a low-resource setting: the Cuban experience. J Hypertens 24 (2006) 845-849
18. Banegas J.R., Segura J., Sobrino J., Rodríguez-Artalejo F., de la Sierra A., de la Cruz J.J., et al. Effectiveness of blood pressure control outside the medical setting. Hypertension 49 (2007) 62-68
19. Ong K.L., Cheung B.M.Y., Man Y.B., Lau C.P., and Lam K.S.L. Prevalence, awareness, treatment, and control of hypertension among Unites States adults 1999-2004. Hypertension 49 (2007) 69-75
20. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel inhibitor vs. diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
21. Levey S.A., Coresh J., Greene T., Stevens L.A., Zhang Y., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study. Equation for estimating glomerular filtration rate. Ann Intern Med 145 (2006) 247-254
22. Onysko J., Maxwell C., Eliaziw M., Zhang J.X., Johansen H., and Campbell N.R.C. Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. Hypertension 48 (2006) 853-860
23. Drouin D., Kaczorowski J., Campbell N.R., and Lewanczuk R.R. Implementing guidelines. It is working in Canada (2008), ESH/ISH Scientific Meeting, Berlin, Germany Abstract OS 14/1